Assignee
DECIBEL THERAPEUTICS INC
US12 patents
Top patents by PatentIndex Score
US11071751B2Jul 27, 2021
Hypertonic pharmaceutical compositions containing an anti-platinum chemoprotectant agent
DECIBEL THERAPEUTICS INC5 citations83
US10709732B2Jul 14, 2020
Hypertonic pharmaceutical compositions containing an anti-platinum chemoprotectant agent
DECIBEL THERAPEUTICS INC6 citations83
US11660353B2May 30, 2023
Compositions and methods for treating sensorineural hearing loss using otoferlin dual vector systems
DECIBEL THERAPEUTICS INC9 citations81
US10813947B1Oct 27, 2020
Methods of otoprotection against platinum-based antineoplastic agents
DECIBEL THERAPEUTICS INC5 citations81
US11857567B2Jan 2, 2024
Hypertonic pharmaceutical compositions containing an anti-platinum chemoprotectant agent
DECIBEL THERAPEUTICS INC2 citations72
US12252520B2Mar 18, 2025
Myosin 15 promoters and uses thereof
DECIBEL THERAPEUTICS INC2 citations70
US12233136B2Feb 25, 2025
Myosin 15 promoters and uses thereof
DECIBEL THERAPEUTICS INC3 citations70
US11690870B2Jul 4, 2023
Methods of otoprotection against platinum-based antineoplastic agents
DECIBEL THERAPEUTICS INC2 citations70
US12410442B2Sep 9, 2025
Compositions and methods for treating sensorineural hearing loss using otoferlin dual vector systems
DECIBEL THERAPEUTICS INC0 citations58
US12534739B2Jan 27, 2026
AAV1 vectors and uses thereof for treatment of otic indications
DECIBEL THERAPEUTICS INC0 citations57
US12545930B2Feb 10, 2026
Cochlear inner hair cell promoters and uses thereof
DECIBEL THERAPEUTICS INC0 citations56
US12589168B2Mar 31, 2026
Compositions and methods for treating sensorineural hearing loss using otoferlin dual vector systems
DECIBEL THERAPEUTICS INC0 citations47